GPX4 and chronic obstructive pulmonary disease: Nevertheless, we concluded that the median serum GPX4 level was lower in the COPD group, at 78.1 (78.1–213.8) pg/mL compared to the control group at 12,307.4 (231.8–23,725.99) pg/mL (p = 0.002).